{"title":"负压物理疗法治疗非器质性勃起功能障碍的有效性：一项多中心随机对照试验","authors":"Long Zhong, Qunlong Liu, Junhua Luo, Lingzhi Tao, Lusha Huang, Zhengping Zhao, Lanxuan Zheng, Kebing Wang, Yu Yang, Benlin Wei","doi":"10.1155/ijcp/8363471","DOIUrl":null,"url":null,"abstract":"<p><b>Background:</b> Erectile dysfunction (ED) is a common male sexual dysfunction characterized by the inability to achieve and maintain an erection sufficient for satisfactory sexual performance. Current therapeutic approaches for this condition have certain limitations.</p><p><b>Objectives:</b> This study aims to investigate the efficacy of negative pressure physical therapy (NPPT) in the rehabilitation and treatment of nonorganic ED.</p><p><b>Methods:</b> This protocol divides subjects into two groups based on different intervention conditions. The experimental group received tadalafil every night before sleep along with the use of a male sexual function therapeutic device, whereas the control group received only tadalafil every night before sleep. A total of 124 patients were enrolled. The recovery and treatment efficacy for sexual dysfunction were evaluated by assessing improvements in erectile difficulty, penile circumference, and penile length.</p><p><b>Results:</b> In the full analysis set (FAS), the estimated mean change in IIEF-5 scores was 4.92 points in the experimental group and 3.13 points in the control group, resulting in a between-group difference of 1.79 points. In the per-protocol set (PPS), the estimated mean change was 4.96 points in the experimental group versus 3.01 points in the control group, with a between-group difference of 1.95 points. In the analysis of changes in penile girth, the experimental group exhibited a mean increase of 0.32 cm (standard deviation [SD] ± 0.44), which was significantly greater than the control group’s increase of 0.14 cm. In the subsequent follow-up 2, the mean girth change in the experimental group further increased to 0.49 cm (SD ± 0.71), whereas the control group showed only a 0.02 cm change; the PPS analysis yielded results consistent with the FAS. Regarding penile length, at follow-up 1, the experimental group demonstrated a mean increase of 0.51 cm (SD ± 0.81), significantly higher than the control group’s 0.19 cm (SD ± 0.32). At follow-up 2, the experimental group’s mean length change rose to 0.39 cm (SD ± 0.45), while the control group exhibited virtually no change (0.00 cm, SD ± 0.05), with the between-group difference being extremely significant (<i>p</i> < 0.0001).</p><p><b>Discussion and Conclusion:</b> NPPT combined with tadalafil exhibited significantly superior efficacy in treating nonorganic ED, providing a safe and effective nonpharmacological option for clinical use.</p>","PeriodicalId":13782,"journal":{"name":"International Journal of Clinical Practice","volume":"2025 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ijcp/8363471","citationCount":"0","resultStr":"{\"title\":\"The Effectiveness of Negative Pressure Physical Therapy in the Management of Nonorganic Erectile Dysfunction: A Multicenter Randomized Controlled Trial\",\"authors\":\"Long Zhong, Qunlong Liu, Junhua Luo, Lingzhi Tao, Lusha Huang, Zhengping Zhao, Lanxuan Zheng, Kebing Wang, Yu Yang, Benlin Wei\",\"doi\":\"10.1155/ijcp/8363471\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Background:</b> Erectile dysfunction (ED) is a common male sexual dysfunction characterized by the inability to achieve and maintain an erection sufficient for satisfactory sexual performance. Current therapeutic approaches for this condition have certain limitations.</p><p><b>Objectives:</b> This study aims to investigate the efficacy of negative pressure physical therapy (NPPT) in the rehabilitation and treatment of nonorganic ED.</p><p><b>Methods:</b> This protocol divides subjects into two groups based on different intervention conditions. The experimental group received tadalafil every night before sleep along with the use of a male sexual function therapeutic device, whereas the control group received only tadalafil every night before sleep. A total of 124 patients were enrolled. The recovery and treatment efficacy for sexual dysfunction were evaluated by assessing improvements in erectile difficulty, penile circumference, and penile length.</p><p><b>Results:</b> In the full analysis set (FAS), the estimated mean change in IIEF-5 scores was 4.92 points in the experimental group and 3.13 points in the control group, resulting in a between-group difference of 1.79 points. In the per-protocol set (PPS), the estimated mean change was 4.96 points in the experimental group versus 3.01 points in the control group, with a between-group difference of 1.95 points. In the analysis of changes in penile girth, the experimental group exhibited a mean increase of 0.32 cm (standard deviation [SD] ± 0.44), which was significantly greater than the control group’s increase of 0.14 cm. In the subsequent follow-up 2, the mean girth change in the experimental group further increased to 0.49 cm (SD ± 0.71), whereas the control group showed only a 0.02 cm change; the PPS analysis yielded results consistent with the FAS. Regarding penile length, at follow-up 1, the experimental group demonstrated a mean increase of 0.51 cm (SD ± 0.81), significantly higher than the control group’s 0.19 cm (SD ± 0.32). At follow-up 2, the experimental group’s mean length change rose to 0.39 cm (SD ± 0.45), while the control group exhibited virtually no change (0.00 cm, SD ± 0.05), with the between-group difference being extremely significant (<i>p</i> < 0.0001).</p><p><b>Discussion and Conclusion:</b> NPPT combined with tadalafil exhibited significantly superior efficacy in treating nonorganic ED, providing a safe and effective nonpharmacological option for clinical use.</p>\",\"PeriodicalId\":13782,\"journal\":{\"name\":\"International Journal of Clinical Practice\",\"volume\":\"2025 1\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ijcp/8363471\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Clinical Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1155/ijcp/8363471\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Practice","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/ijcp/8363471","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景：勃起功能障碍（ED）是一种常见的男性性功能障碍，其特征是无法达到和维持足以满足性行为的勃起。目前的治疗方法有一定的局限性。目的：探讨负压物理疗法（NPPT）在非器质性ed康复治疗中的疗效。方法：本方案根据不同的干预条件将受试者分为两组。实验组每晚睡前服用他达拉非，同时使用男性性功能治疗仪，而对照组每晚睡前只服用他达拉非。共有124名患者入组。通过评估勃起困难、阴茎周长和阴茎长度的改善来评估性功能障碍的恢复和治疗效果。结果：在全分析集（FAS）中，实验组IIEF-5评分的估计平均变化为4.92分，对照组为3.13分，组间差异为1.79分。在每方案集（PPS）中，实验组的估计平均变化为4.96分，对照组为3.01分，组间差异为1.95分。在阴茎周长变化分析中，实验组平均增加0.32 cm（标准差[SD]±0.44），明显大于对照组增加0.14 cm。在随后的随访2中，实验组的平均周长变化进一步增大至0.49 cm (SD±0.71)，而对照组仅变化0.02 cm；PPS分析的结果与FAS一致。在随访1时，实验组阴茎长度平均增加0.51 cm (SD±0.81)，明显高于对照组的0.19 cm （SD±0.32）。随访2时，实验组平均长度变化为0.39 cm (SD±0.45)，对照组基本无变化（0.00 cm, SD±0.05），组间差异极显著（p < 0.0001）。讨论与结论：NPPT联合他达拉非治疗非器质性ED的疗效显著优于非器质性ED，为临床应用提供了安全有效的非药物选择。
The Effectiveness of Negative Pressure Physical Therapy in the Management of Nonorganic Erectile Dysfunction: A Multicenter Randomized Controlled Trial
Background: Erectile dysfunction (ED) is a common male sexual dysfunction characterized by the inability to achieve and maintain an erection sufficient for satisfactory sexual performance. Current therapeutic approaches for this condition have certain limitations.
Objectives: This study aims to investigate the efficacy of negative pressure physical therapy (NPPT) in the rehabilitation and treatment of nonorganic ED.
Methods: This protocol divides subjects into two groups based on different intervention conditions. The experimental group received tadalafil every night before sleep along with the use of a male sexual function therapeutic device, whereas the control group received only tadalafil every night before sleep. A total of 124 patients were enrolled. The recovery and treatment efficacy for sexual dysfunction were evaluated by assessing improvements in erectile difficulty, penile circumference, and penile length.
Results: In the full analysis set (FAS), the estimated mean change in IIEF-5 scores was 4.92 points in the experimental group and 3.13 points in the control group, resulting in a between-group difference of 1.79 points. In the per-protocol set (PPS), the estimated mean change was 4.96 points in the experimental group versus 3.01 points in the control group, with a between-group difference of 1.95 points. In the analysis of changes in penile girth, the experimental group exhibited a mean increase of 0.32 cm (standard deviation [SD] ± 0.44), which was significantly greater than the control group’s increase of 0.14 cm. In the subsequent follow-up 2, the mean girth change in the experimental group further increased to 0.49 cm (SD ± 0.71), whereas the control group showed only a 0.02 cm change; the PPS analysis yielded results consistent with the FAS. Regarding penile length, at follow-up 1, the experimental group demonstrated a mean increase of 0.51 cm (SD ± 0.81), significantly higher than the control group’s 0.19 cm (SD ± 0.32). At follow-up 2, the experimental group’s mean length change rose to 0.39 cm (SD ± 0.45), while the control group exhibited virtually no change (0.00 cm, SD ± 0.05), with the between-group difference being extremely significant (p < 0.0001).
Discussion and Conclusion: NPPT combined with tadalafil exhibited significantly superior efficacy in treating nonorganic ED, providing a safe and effective nonpharmacological option for clinical use.
期刊介绍：
IJCP is a general medical journal. IJCP gives special priority to work that has international appeal.
IJCP publishes:
Editorials. IJCP Editorials are commissioned. [Peer reviewed at the editor''s discretion]
Perspectives. Most IJCP Perspectives are commissioned. Example. [Peer reviewed at the editor''s discretion]
Study design and interpretation. Example. [Always peer reviewed]
Original data from clinical investigations. In particular: Primary research papers from RCTs, observational studies, epidemiological studies; pre-specified sub-analyses; pooled analyses. [Always peer reviewed]
Meta-analyses. [Always peer reviewed]
Systematic reviews. From October 2009, special priority will be given to systematic reviews. [Always peer reviewed]
Non-systematic/narrative reviews. From October 2009, reviews that are not systematic will be considered only if they include a discrete Methods section that must explicitly describe the authors'' approach. Special priority will, however, be given to systematic reviews. [Always peer reviewed]
''How to…'' papers. Example. [Always peer reviewed]
Consensus statements. [Always peer reviewed] Short reports. [Always peer reviewed]
Letters. [Peer reviewed at the editor''s discretion]
International scope
IJCP publishes work from investigators globally. Around 30% of IJCP articles list an author from the UK. Around 30% of IJCP articles list an author from the USA or Canada. Around 45% of IJCP articles list an author from a European country that is not the UK. Around 15% of articles published in IJCP list an author from a country in the Asia-Pacific region.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
